durvalumab
astrazeneca
['durvalumab', 'mesothelioma']
at the #asco22 clinical controversies session on #mesothelioma? read about the phase ii trial on durvalumab plus platinum-pemetrexed for unresectable mesothelioma led by speaker 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.